23 and me glp-1 23andMe Research Team Publishes Study on Medication Response in Nature | Adam Auton posted on the topic As a medical school professor,

GLP-1 increases insulin secretion in response to nutrients and suppresses glucagon secretion from pancreatic islet cells, reducing postprandial glucose levels ( Some studies suggest that GLP-1 RAs may benefit kidney outcomes, especially in improving albuminuria ( Others Endothelin receptor antagonists (ERAs) such as atrasentan and eprosartan have been associated with renal protection when combined with RAAS blockade ( Conclusions Nephroprotection is a cornerstone in preserving renal damage in patients with lupus nephritis ( Figure 1 )

This may be due to its dual-action mechanism, and it has been observed in randomized trials as well as non-randomized studies

These findings highlight Mounjaros potential to support patients beyond blood sugar control

Available via Accessed 17 Jan 2020:125 Thirumoorthy N, Manisenthil Kumar KT, Shyam Sundar A, Panayappan L, Chatterjee M (2007) Metallothionein: an overview